Viewing Study NCT04628494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-03-10 @ 11:51 PM
Study NCT ID: NCT04628494
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2020-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Sponsor: Genmab
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Large B-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None double-hit DLBCL View
None triple-hit DLBCL View
None follicular grade 3B View
None transformed DLBCL View
None T-cell histiocytes-rich large B cell lymphoma View